Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tocolysis: current controversies, future directions.

Stephen Cole1, Roger Smith, Warwick Giles

  • 1Department of Maternal-Fetal Medicine, Royal Women's Hospital, Grattan Street, Carlton, VIC 3053, Australia. stevecole@bigpond.com

Current Opinion in Investigational Drugs (London, England : 2000)
|May 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Birthweight phenotype genotype mismatch in cardiometabolic programming.

Communications medicine·2026
Same author

Combinational tocolysis: evaluating lower-dose combinations of nifedipine, indomethacin, and aminophylline for tocolytic synergism in pregnant human myometrium.

American journal of obstetrics and gynecology·2026
Same author

Challenging Gram-negative Infections: Perspectives from a Clinician and a Microbiologist.

The Veterinary clinics of North America. Small animal practice·2026
Same author

Global Trends in Maternal Mortality and Efforts to Improve Maternal Outcomes Through Sociomedical Interventions.

Reproductive sciences (Thousand Oaks, Calif.)·2026
Same author

Pregnancy Hormones and Offspring Psychiatric Problems: Testing Associations Between Placental Corticotropin-Releasing Hormone and Children's Age 8 Internalizing Outcomes.

Biopsychosocial science and medicine·2026
Same author

Models, outcomes, barriers, and facilitators of supportive care in cancer: a scoping review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011
Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010
See all related articles

Current evidence does not support tocolytic agents for preterm labor treatment, despite their common use. Research quality is poor, necessitating better studies focusing on health outcomes, not just pregnancy duration.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Reproductive Medicine

Background:

  • Tocolytic agents are frequently used to manage preterm labor, but evidence supporting their efficacy is limited.
  • The complex physiology of parturition and potential harm from labor suppression may explain the lack of observed benefits.
  • Existing studies are often underpowered, compromising the reliability of evidence regarding health outcomes.

Purpose of the Study:

  • To critically evaluate the current evidence for tocolytic agents in treating preterm labor.
  • To identify limitations in existing research and propose future directions for tocolytic therapy.
  • To emphasize the need for outcome-focused research in preterm labor management.

Main Methods:

  • Review of placebo-controlled trials on tocolytic agents for preterm labor.

Related Experiment Videos

  • Analysis of current clinical practices and trends in tocolytic use.
  • Discussion of physiological factors and limitations of current evidence.

    • Main Results:

    • Placebo-controlled trials do not currently support the use of tocolytic agents for preterm labor.
    • Evidence quality is poor due to underpowered studies and methodological limitations.
    • Clinical trends favor tocolytics with better maternal side effect profiles, such as calcium channel blockers and atosiban.

    Conclusions:

    • The efficacy of tocolytic agents for preterm labor remains unsupported by robust evidence.
    • Future research must prioritize evaluating health outcomes and employ well-designed, adequately powered clinical studies.
    • Development of more selective agents and combination therapies with favorable side effect profiles is warranted.